These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1207292)

  • 1. [Cell cycle and carcinochemotherapy: reality or hope? (author's transl)].
    Ehrhart H
    Langenbecks Arch Chir; 1975 Nov; 339():127-33. PubMed ID: 1207292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of high-dosage attack treatment with cytostatics in mammary and ovarian cancer (author's transl)].
    Möhlen KH; Beller FK
    Strahlentherapie; 1978 Sep; 154(9):622-6. PubMed ID: 684782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary experiences in the treatment of metastatic mamma carcinoma by polychemotherapy-according to Cooper (author's transl)].
    Barndt J
    Radiobiol Radiother (Berl); 1976; 17(3):355-63. PubMed ID: 981540
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
    Nüvemann M; Fernholz HJ; Frik W
    Med Klin; 1976 Oct; 71(40):1676-83. PubMed ID: 184372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy using cyclophosphamide, vincristine, methotrexate, 5-fluorouracil, and prednisone in solid tumors.
    Bearden JD; Coltman CA; Moon TE; Costanzi JJ; Saiki JH; Balcerzak SP; Rivkin SE; Morrison FS; Lane M; Spigel SC
    Cancer; 1977 Jan; 39(1):21-6. PubMed ID: 832235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of VCR-5FU-CYCLO-PDN in the treatment of disseminated carcinoma of the breast (author's transl)].
    Estapé J; Millá A; Prats M; Herranz M; Visa J
    Med Clin (Barc); 1979 Aug; 73(4):136-9. PubMed ID: 481010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment of cancer. II. Breast carcinoma.
    Viola MV; Nystrom JS
    Conn Med; 1977 Jun; 41(6):333-5. PubMed ID: 872584
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy in disseminated carcinoma of the breast.
    Stutz FH; Blom J; Tormey DC
    Oncology; 1974; 29(2):139-46. PubMed ID: 4525917
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA; Grillo-López A; Vélez-Garciá E
    Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
    Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
    Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 15. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
    Byland W; Nagel G; Senn HJ
    Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemical therapy of breast cancer.
    Carter SK
    Semin Oncol; 1974 Jun; 1(2):131-44. PubMed ID: 4220126
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Principles of the effect of cytostatics].
    Siering VH; Abendroth K
    Z Gesamte Inn Med; 1974 Nov; 29(21):866-70. PubMed ID: 4142666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.